Clinical trials have complex eligibility criteria.Always talk to your clinician about you’re interest in participating in a trial.Learn why
HP Version - Clinical trials have complex eligibility criteria.Always talk to your clinician about you’re interest in participating in a trial.Learn why
Optimise reading forHealth ProfessionalsPatients
CompletedLast updated: 5 February 2024
Clinical summaryEligibilityParticipating hospitalsSupport
This trial groups together into a single protocol the treatment of all patients with "non high risk" neuroblastoma, with stratification into two groups: low risk and intermediate risk. Treatment may include chemotherapy, surgery and radiotherapy, or a combination of these treatments, depending on individual cases.
This trial is treating patients with neuroblastoma.
Brain and Spinal
0 - 18
III
SIOPEN LINES
Use the hyperlinks, where available to access additional clinical trial information.
Instituto de Investigacion Sanitaria La Fe
European Low and Intermediate Risk Neuroblastoma Protocol
Brain and spinal cord
Share with email
Print this page
Download brochure
LOW RISK STUDY
Inclusion criteria for the whole low risk group:
Exclusion criteria for the whole low risk group:
* Diagnosis of ganglioneuroma or ganglioneuroblastoma intermixed INRG Stage L2
Inclusion criteria:
*age ≤ 18 months
Exclusion criteria:
* age ≤ 12 months
INTERMEDIATE RISK STUDY
Inclusion criteria for the whole intermediate risk group:
Exclusion criteria for the whole intermediate risk group:
* Diagnosis of ganglioneuroma or ganglioneuroblastoma intermixed
INRG Stage L1 and INSS stage 1:
* MYCN amplified
INRG Stage L2:
INRG Stage M:
Clinical trials have complex eligibility criteria.
Ask your doctor if this trial could be right for you.
+ Show non-recruiting hospitals
Tell us if you find this trial availability is not accurate.Report inaccuracy
Speak with someone who has cancer clinical trial experience.
Learn more
If you need cancer information and practical support for yourself, a carer, family or friend, contact Cancer Council’s experienced cancer nurses on 131120.
When you are considering a cancer clinical trial, it is a good idea to discuss it with your family, friends or carers.
Thank you for helping us to increase accuracy of the trial. Our team will validate the information and update the information as soon as possible.